ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Applied Therapeutics Inc

Applied Therapeutics Inc (APLT)

0.53
-0.0352
(-6.23%)
마감 24 2월 6:00AM
0.5447
0.0147
(2.77%)
시간외 거래: 9:51AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
0.5447
매수가
0.5315
매도가
0.5455
거래량
3,371,101
0.5307 일간 변동폭 0.593
0.53 52주 범위 10.6237
market_cap
전일 종가
0.5652
개장가
0.5612
최근 거래 시간
50
@
0.5455
마지막 거래 시간
재정 규모
US$ 1,853,305
VWAP
0.549763
평균 볼륨(3m)
7,543,651
발행 주식
116,356,474
배당수익률
-
주가수익률
-0.51
주당순이익(EPS)
-1.03
매출
9.99M
순이익
-119.76M

Applied Therapeutics Inc 정보

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic expos... Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
본부
Wilmington, Delaware, USA
설립됨
-
Applied Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker APLT. The last closing price for Applied Therapeutics was US$0.57. Over the last year, Applied Therapeutics shares have traded in a share price range of US$ 0.53 to US$ 10.6237.

Applied Therapeutics currently has 116,356,474 shares in issue. The market capitalisation of Applied Therapeutics is US$65.76 million. Applied Therapeutics has a price to earnings ratio (PE ratio) of -0.51.

APLT 최신 뉴스

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.0465-7.865358592690.59120.69780.5335962850.59283896CS
4-0.0653-10.70491803280.610.69780.5329340160.58809028CS
12-1.6353-75.01376146792.182.440.5375436511.10887497CS
26-5.3553-90.76779661025.910.62370.5348566533.42428079CS
52-4.6153-89.44379844965.1610.62370.5330010783.85566651CS
156-1.6653-75.35294117652.2110.62370.499514006393.38435648CS
260-41.2053-98.695329341341.7551.990.49959018714.72255763CS

APLT - Frequently Asked Questions (FAQ)

What is the current Applied Therapeutics share price?
The current share price of Applied Therapeutics is US$ 0.5447
How many Applied Therapeutics shares are in issue?
Applied Therapeutics has 116,356,474 shares in issue
What is the market cap of Applied Therapeutics?
The market capitalisation of Applied Therapeutics is USD 65.76M
What is the 1 year trading range for Applied Therapeutics share price?
Applied Therapeutics has traded in the range of US$ 0.53 to US$ 10.6237 during the past year
What is the PE ratio of Applied Therapeutics?
The price to earnings ratio of Applied Therapeutics is -0.51
What is the cash to sales ratio of Applied Therapeutics?
The cash to sales ratio of Applied Therapeutics is 6.17
What is the reporting currency for Applied Therapeutics?
Applied Therapeutics reports financial results in USD
What is the latest annual turnover for Applied Therapeutics?
The latest annual turnover of Applied Therapeutics is USD 9.99M
What is the latest annual profit for Applied Therapeutics?
The latest annual profit of Applied Therapeutics is USD -119.76M
What is the registered address of Applied Therapeutics?
The registered address for Applied Therapeutics is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, NEW CASTLE, WILMINGTON, DELAWARE, 19810
What is the Applied Therapeutics website address?
The website address for Applied Therapeutics is www.appliedtherapeutics.com
Which industry sector does Applied Therapeutics operate in?
Applied Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MLGOMicroAlgo Inc
US$ 6.3767
(454.50%)
531.54M
BOXLBoxlight Corporation
US$ 3.1099
(51.70%)
1.84M
GDEVGDEV Inc
US$ 20.90
(46.56%)
264.44k
IVVDInvivyd Inc
US$ 1.7501
(44.64%)
37.75M
UPCUniverse Pharmaceuticals Inc
US$ 0.2003
(40.56%)
420.21M
DOYUDouYu International Holdings Ltd
US$ 7.19
(-55.31%)
1.28M
MNDRMobile health Network Solutions
US$ 0.5048
(-46.29%)
18.61M
BLUEbluebird bio Inc
US$ 4.09
(-41.90%)
5.44M
GCLGCL Global Holdings Ltd
US$ 3.83
(-31.48%)
635.26k
AXTIAXT Inc
US$ 1.57
(-31.44%)
6.66M
MLGOMicroAlgo Inc
US$ 6.3767
(454.50%)
531.54M
UPCUniverse Pharmaceuticals Inc
US$ 0.2003
(40.56%)
420.21M
ADTXAditxt Inc
US$ 0.0922
(-22.39%)
278.25M
NVDANVIDIA Corporation
US$ 134.43
(-4.05%)
228.15M
HOLOMicroCloud Hologram Inc
US$ 1.565
(31.51%)
190.81M

APLT Discussion

게시물 보기
Lonewolf1 Lonewolf1 5 일 전
DESPERATE manipulation going on courtesy of the ambulance chasers. 

Double coming soon - maybe much more. LOL

$APLT$
👍️0
glenn1919 glenn1919 5 일 전
APLT.................................https://stockcharts.com/h-sc/ui?s=APLT&p=W&b=5&g=0&id=p86431144783
👍️0
Lonewolf1 Lonewolf1 1 주 전
Easy DOUBLE coming up here soon.

$APLT$

YES
👍️0
glenn1919 glenn1919 1 주 전
APLT..............................................https://stockcharts.com/h-sc/ui?s=APLT&p=W&b=5&g=0&id=p86431144783
👍️0
Lonewolf1 Lonewolf1 2 주 전
Added 3000 today at .5407.

$APLT$
👍️0
Lonewolf1 Lonewolf1 2 주 전
And what will happen with all the frivolous lawsuits?

When the price triples in one day from here, the stock will continue to recover, moving higher and higher until the lawsuits, along with our ambulance chaser friends will look like bafoons.

YES

$APLT$
👍️0
Lonewolf1 Lonewolf1 2 주 전
APLT's strategy is to present to the FDA  in Q1 of 2025 their results Galactosemia, SORD Deficiency, and PMM2-CDG. The company is also developing AT-001 for Diabetic Cardiomyopathy and Diabetic Peripheral Neuropathy, and AT-003 for Diabetic Retinopathy, addressing significant unmet needs in diabetes care.


If ANY of these results have ANY success, we are looking at a four bagger in a single day from these levels.


The risk/reward is highly attractive.
👍️0
Lonewolf1 Lonewolf1 1 월 전
Short covering has officially begun. 😁
👍️0
Lonewolf1 Lonewolf1 1 월 전
It's up from here. Maybe a few shenanigans are still in store, but it's up from here.

Would not be surprised to see a double suddenly on a volume spike. Just look at the time and sales from last Friday.

About 5 million shares were bought in the last 5 minutes of trading. Somebody knows something.
👍️0
Lonewolf1 Lonewolf1 1 월 전
Was this the bottom?

Jumped in with a starter at .64

Any halfway decent news will spike this IMHO.
👍️0
Lonewolf1 Lonewolf1 1 월 전






👍️0
Lonewolf1 Lonewolf1 1 월 전
The company has been totally "crickets" since the debacle of some weeks ago.

But truth be told, a decent PR from theses folks could send this spiking to the upside.

All you need is a few cojones. lol😅
👍️0
glenn1919 glenn1919 2 월 전
APLT...................https://stockcharts.com/h-sc/ui?s=APLT&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 월 전
aplt.............................................https://stockcharts.com/h-sc/ui?&s=aplt&id=p80904663129&listNum=4&a=1431976465
👍️0
firebag1 firebag1 2 월 전
What is the Lawsuit About?

Applied Therapeutics is a clinical-stage biopharmaceutical company specializing in the development of novel drug candidates against validated molecular targets in rare diseases. The Company's lead drug candidate, govorestat, is a central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases, including Galactosemia.

During the relevant period, the Company stated that its New Drug Applications submitted to regulators for govorestat were“supported by rapid and sustained reduction in galactitol, which resulted in a meaningful benefit on clinical outcomes across pediatric patients, alongside a favorable safety profile.” Applied Therapeutics also assured investors that its tests were“performed properly” and that the Company“felt good about the quality of the data,” stating that it“took really extensive steps” and“actually videotaped” and had“master trainers” review all of the performances of the 10-meter walk-run test-the primary endpoint of the Company's Phase III INSPIRE study for govorestat.

The Stock Declines as the Truth is Revealed
On November 27, 2024, Applied Therapeutics issued a press release stating that the FDA issued a Complete Response Letter for the NDA for govorestat. The Complete Response Letter stated that the FDA completed its review of the application and determined that it was unable to approve the NDA due to“deficiencies in the clinical application.”

This news caused the price of Applied Therapeutics stock to fall more than 80% over the course of multiple trading days, from a closing price of $10.21 per share on November 26, 2024 to a closing price of $1.75 per share on December 2, 2024.

Then, on December 2, 2024, Applied Therapeutics revealed that it received a warning letter from the FDA relating to its govorestat study discussing“issues related to electronic data capture” and“a dosing error in the dose-escalation phase of the study resulting in slightly lower levels than targeted in a limited number of patients[.]”

This news caused the price of Applied Therapeutics stock to fall more than 26% over the course of multiple trading days, from a closing price of $1.75 per share on December 2, 2024 to a closing price of $1.29 per share on December 5, 2024.

Click here for more information: .

What Can You Do?

If you invested in Applied Therapeutics you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


Or contact:
Ross Shikowitz
...
212-789-3619

Why Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs' Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit .


Attorney advertising. Past results do not guarantee future outcomes.




MENAFN01012025004107003653ID1109046768


GlobeNewsWire - Nasdaq
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.


Tags

Label
Comments

No comment
Category


Date

1/1/2025

Most popular stories
Poland Assumes EU Council Presidency With Focus On Security...
Poland Assumes EU Council Presidency With Focus On Security...
When Will Rigetti And These Two Stock Rally End?...
When Will Rigetti And These Two Stock Rally End?...
Dubai: Is It Time To Shift From Gold To Diamonds? Changing Jewellery T...
Dubai: Is It Time To Shift From Gold To Diamonds? Changing Jewellery T...
Dubai: Gold Prices Jump In Early Trade On New Year, Set To Stay High I...
Dubai: Gold Prices Jump In Early Trade On New Year, Set To Stay High I...
'Bruce Lee Of Afghanistan' Dreams Visting Hong Kong, Performing In Mov...
'Bruce Lee Of Afghanistan' Dreams Visting Hong Kong, Performing In Mov...
M&M 11Th Most Valuable Automobile Manufacturer In World: Anand Mahindr...
M&M 11Th Most Valuable Automobile Manufacturer In World: Anand Mahindr...

Market Research
Market Research

Manuka Honey Market Report 2024, Industry Growth, Size, Share, Top Compan...
Modular Kitchen Market 2024, Industry Growth, Share, Size, Key Players An...
Acrylamide Production Cost Analysis Report: A Comprehensive Assessment Of...
Fish Sauce Market 2024, Industry Trends, Growth, Demand And Analysis Repo...
Australia Foreign Exchange Market Size, Growth, Industry Demand And Forec...
Cold Pressed Oil Market Trends 2024, Leading Companies Share, Size And Fo...
Pasta Sauce Market 2024, Industry Growth, Share, Size, Key Players Analys...
👍️0
Law of Averages Law of Averages 2 월 전
APLT on the move here.
👍️0
green maschine green maschine 3 월 전
I see a great opportunity here at these levels. That price drop was quite exaggerated.
👍️0
morokoy morokoy 5 월 전
Option trade today 1/17/25, $12.50 @1,000
👍️0
morokoy morokoy 5 월 전
Option trade today 1/17/25, $12.50 @1,000
👍️0
Invest-in-America Invest-in-America 5 월 전
APLT: 200%-up, for sure today.
👍️0
Awl416 Awl416 5 월 전
Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
👍️0
Monksdream Monksdream 6 월 전
APLT under $7
👍️0
Monksdream Monksdream 10 월 전
APLT under $5
👍️0
InvestorPhilia4 InvestorPhilia4 11 월 전
I have held this for several years and there are many prospects progressing. I like the significant CEO ownership position.
👍️0
Monksdream Monksdream 12 월 전
APLT new 52 week high
👍️0
Monksdream Monksdream 12 월 전
APLT new 52 week high
👍️0
ddt60 ddt60 12 월 전
Outstanding
👍️0
Awl416 Awl416 12 월 전
Applied Therapeutics Announces $100 Million Private Placement
👍️0
Nadendla Nadendla 1 년 전
OMG.. really..
👍️0
Nadendla Nadendla 1 년 전
yup.. my mistake that i overlooked you.. you will financial crisis for the next 3 years..
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT what a beast and not one ihubber talking. The best kind!
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT...NEXT MONSTER BIO BEAST!!!
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT...HUGE BREAK OUT PLAY
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT..THE NEXT BIO BEAST THAT WILL BEAST THROUGH BEASTVILLE
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT...4.47 HERE WE COME
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT...ANOTHER MONSTER IN THE MAKING
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT..HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT STRONG TREND IN PLACE
👍️0
ddt60 ddt60 1 년 전
Maybe this could run back up to where it was 4 years ago.
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT...HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT READY TO BLOW UP ONCE AGAIN
👍️0
stock1ace1 stock1ace1 1 년 전
Aplt $3.10 pending news
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
back in on break out
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT...THE MONSTER IS RUNNING HARD NOW
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT..HERES THE BREAK OUT...WEEKLY TRAND IN PLACE LIKE YOU HAVE NEVER SEEN
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT HAS THE BEST WEEKLY CHART OF ANY BIO OUT THERE
👍️0
halbroke1 halbroke1 1 년 전
Trend $$$ Great Pick with APLT $$$, I agree 100% here... Could easily Go To $10.00+ or Higher....EOD & After_Hours could get Wild..
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
wowza...look at her go
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT...READY FOR 2.67...MONSTER
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
APLT MONSTER IN THE MAKING...WEEKLY BLOW OUT TREND IN PLACE
👍️0

최근 히스토리

Delayed Upgrade Clock